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Both caloric restriction (CR) and low-protein, high-
carbohydrate (LPHC) ad-libitum-fed diets increase
lifespan and improve metabolic parameters such
as insulin, glucose, and blood lipids. Severe CR,
however, is unsustainable for most people; there-
fore, it is important to determine whether manipu-
lating macronutrient ratios in ad-libitum-fed condi-
tions can generate similar health outcomes. We
present the results of a short-term (8 week) dietary
manipulation on metabolic outcomes in mice. We
compared three diets varying in protein to carbohy-
drate ratio under both CR and ad libitum conditions.
Ad libitum LPHC diets delivered similar benefits to
CR in terms of levels of insulin, glucose, lipids,
and HOMA, despite increased energy intake. CR
on LPHC diets did not provide additional benefits
relative to ad libitum LPHC. We show that LPHC
diets under ad-libitum-fed conditions generate the
metabolic benefits of CR without a 40% reduction
in total caloric intake.
INTRODUCTION
Caloric restriction (CR) of 30%–50% increases healthspan,
delays the onset of aging and age-associated diseases, and
improves metabolic health in most species (Everitt et al.,
2010; Masoro, 2005; Mattison et al., 2012; McCay et al.,
1935; Mercken et al., 2012; Weindruch et al., 1986). It is gener-
ally thought that CR is mediated directly by the reduction in en-
ergy intake impacting on cellular substrates such as NAD+ and
AMP, with subsequent downstream effects on nutrient-sensing
pathways such as sirtuin (SIRT1), AMP-activated protein kinase
(AMPK), mechanistic target of rapamycin (mTOR), and insulin/
insulin growth factor 1 (IGF-1) (Brunet et al., 2004; Fontana
et al., 2010; Le Couteur et al., 2012). Although beneficial, CR
is unsustainable in the vast majority of humans (Fontana and
Partridge, 2015).CeMore recently, it has been demonstrated in studies using
nutritional geometry that the balance of macronutrients has a
profound impact on healthspan and lifespan in animals with ad
libitum (AL) access to food (Lee et al., 2008; Piper et al., 2011;
Solon-Biet et al., 2014). In these studies, CR induced by dietary
dilution did not increase lifespan (Solon-Biet et al., 2014). In
AL-fed mice and Drosophila melanogaster, diets low in protein
and high in carbohydrates (LPHC) maximized lifespan, while a
reduction of total energy intake had no positive impact on
longevity (Lee et al., 2008; Solon-Biet et al., 2014). Moreover in
mice, LPHC diets were associated with improved late-life cardi-
ometabolic health (Solon-Biet et al., 2014) and a younger im-
mune profile (Le Couteur et al., 2014). Low protein intake has
also been associated with better health and reduced mortality
in observational studies of humans (Levine et al., 2014), while
high-protein, low-carbohydrate (HPLC) diets are associated
with higher mortality, cardiovascular disease, and diabetes mel-
litus (Fontana and Partridge, 2015; Fung et al., 2010; Lagiou
et al., 2012; Simpson et al., 2015).
Thus, a diet with altered macronutrient composition may be a
more feasible intervention than severe CR for managing meta-
bolic health in humans. However, there is a downside: whereas
LPHC diets have beneficial effects later in life, they are associ-
atedwith increased food intake, driven by compensatory feeding
for protein (Gosby et al., 2011; Huang et al., 2013; Raubenheimer
et al., 2015; Simpson andRaubenheimer, 2005). The clinical con-
sequences of overconsumption are well established, including
obesity, metabolic syndrome, type 2 diabetes mellitus, and fatty
liver (Dietrich and Hellerbrand, 2014; Nseir et al., 2014; Simpson
et al., 2015). Overall, reducing food intake and body weight im-
proves the manifestations of metabolic syndrome and fatty liver
(Ajala et al., 2013; Nseir et al., 2014). Effects ofmacronutrients on
these outcomes in humans are less clear, but, in general, high-
carbohydrate diets are thought to contribute to fatty liver and
metabolic syndrome, while high-protein diets might be protec-
tive (Nseir et al., 2014), in part through aiding reduced energy
intake (Gosby et al., 2014).
The question arises as to which dietary intervention is more
effective at improving metabolic health and whether there is
any synergy between these dietary regimens. In this study,
we directly compared CR with diets differing in protein toll Reports 11, 1529–1534, June 16, 2015 ª2015 The Authors 1529
Figure 1. Food and Energy Intake ± SEM
(A) Average food intake (g/day), (B) energy intake (kJ/day), and (C) body mass
(g) over 8 weeks of feeding in AL and CR regimens. Note that CR animals were
offered exactly 40% of AL counterparts fed the same diet composition (HPLC,
MPMC, or LPHC). See also Table S2.carbohydrate ratio and evaluated several metabolic and hepatic
outcomes. The results indicate that LPHC diets under AL-feed-
ing conditions achieve the metabolic gains seen with CR. As ex-
pected, LPHC was associated with increased energy intake, but
over a period of 8 weeks this was counterbalanced by increased
energy expenditure and did not lead to a significant increase in
body adiposity or fatty liver. Additional health improvements
were not achieved by combining CR with LPHC diets, although
CR prevented the negative metabolic consequences of a
HPLC diet in AL-fed mice.
RESULTS
Food and Energy Intake
Dietary protein to carbohydrate balance (P:C) influenced food
and energy intakes in AL-fed animals (Figures 1A and 1B). AL
mice titrated their food intake according to percent dietary
protein, with animals on AL LPHC diet consuming the greatest
amounts of food and energy. After the 8-week dietary interven-
tion, CR animals had reduced body mass compared with AL-fed
animals, while mice on the ALmedium P:C (MPMC) diets had the
highest body mass (Figure 1C).
Diet and Feeding Regimen Influences Metabolic
Phenotype
After 8 weeks, AL HPLC animals demonstrated significantly
higher insulin levels and HOMA values and impaired glucose
tolerance, relative to other treatment groups (Figures 2A–2E;
Figure S1; Table S2). These parameters were more favorable
in AL-fed animals with lower dietary P:C. AL LPHC mice
showed improved insulin, HOMA, triglyceride, and HDLc levels1530 Cell Reports 11, 1529–1534, June 16, 2015 ª2015 The Authorscompared with the other AL diets, and their results are compara-
ble to those found in CR-fed animals. These same outcomes
were also improved to a similar extent in all CR treatments,
regardless of dietary P:C (Table S2). Triglycerides followed a
similar pattern, with highest levels in the animals on the AL
HPLC and ALMPMC diets, while there were no significant differ-
ences between the AL LPHC diets and any of the CR diets. A
similar trend was seen for HDLc where the lowest (worse) values
were seen for the AL HPLC and AL MPMC diets.
Liver and Pancreatic Pathology
All diets were associated with normal liver histology regardless
of whether mice were fed AL or CR (Figures 3A and 3B). There
were subtle changes in the porosity of the liver sinusoidal endo-
thelium, with lower porosity observed in LPHC compared with
MPMC or HPLC mice (1.13% ± 0.11% versus 1.63% ±
0.12%, p = 0.02; Figures 3C and 3D). There were no obvious
changes in pancreatic islet pathology or pancreatic insulin
stains (c2 = 2.33, df = 5, p = 0.8; Figure S2), but there was
an increase in the intensity of staining for glucagon in AL
HPLC mice compared to all other groups (c2 = 26.09, df = 5,
p % 0.0001; Figures 3E–3G). This suggests the AL HPLC diet
results in increased glucagon secretion, causing elevated blood
glucose levels, and glucose intolerance. The higher insulin and
HOMA levels observed (Figures 2A and 2B) are consistent with
this notion.
Energy Expenditure, RER, and Body Composition
Energy expenditure was significantly higher in the AL LPHC
animals compared to all of the CR animals. The respiratory
exchange ratio (RER) approached 1 in the AL LPHC animals,
indicating carbohydrate was the primary source of energy,
compared to the other groups, where the value approached
0.7, indicating utilization of fat (Figure 4A; Table S2). There
were discernible effects of dietary interventions on body compo-
sition. Body mass was lower in the CR animals (Figure 1C) while,
interestingly, percentage body fat showed opposing patterns,
with animals in CR groups tending to have increased adiposity
(relative to lean mass) (Figure 4C).
DISCUSSION
Our results provide a direct comparison of CR to AL LPHC di-
ets, to determine whether it is possible to generate similar
metabolic outcomes achieved with CR using AL diets. Our re-
sults show that, after 8 weeks, AL-fed LPHC mice had similar
metabolic improvements as seen under CR, despite increased
energy intake, but without the development of increased body
adiposity and fatty liver that is observed in longer-term chronic
LPHC feeding. Manipulating dietary P:C ratios in animals under
CR conditions did not generate any additional benefits in terms
of these outcomes, nor did it cause any detrimental effects to
the mice.
Mice, like humans and various other species, demonstrate
‘‘protein leverage,’’ where protein intake is prioritized over fat
and carbohydrates (Gosby et al., 2011; Raubenheimer et al.,
2015; Simpson and Raubenheimer, 2005). Such an effect was
evident in the present study, with the AL LPHC diet resulting in
Figure 2. Metabolic Phenotype ± SEM
The effect of diets on (A) insulin, (B) HOMA, (C) triglycerides, (D) HDLc, and (E) oral glucose tolerance tests. (AL, ad libitum; CR, caloric restricted; HPLC, high ratio
of protein to carbohydrate; MPMC, medium protein to carbohydrate ratio; LPHC, low protein to carbohydrate ratio). See also Tables S2 and S3.increased food and energy intake of about 25%–30% compared
to the AL HPLC diet. Despite this elevated intake, we did not
observe increased adiposity, body weight, or diet-induced
fatty liver in AL LPHC mice. They did, however, show increased
energy expenditure, which is consistent with increased diet-
induced thermogenesis (DIT) serving to dissipate excess in-
gested energy and slow development of adiposity (Huang
et al., 2013; Stock, 1999).
Exposure to LPHC diets over longer time periods, however,
has been associated with increased body weight, adiposity,
and fatty liver (Huang et al., 2013; Solon-Biet et al., 2014; Sør-
ensen et al., 2008), indicating that mechanisms for compensa-
tory energy expenditure may become progressively less effec-
tive with time (Huang et al., 2013). Such mice, albeit more
adipose, nonetheless have improved cardiometabolic out-
comes, including insulin, GTT, HOMA, lipids, and blood pres-
sure (Solon-Biet et al., 2014). It is also important to consider
the type of carbohydrate consumed (e.g., starch versus fruc-
tose versus glucose [Wylie-Rosett et al., 2004]) as this has
been shown in rodent studies to have a profound influence
on the development of obesity and insulin resistance (Maki
and Phillips, 2015; Storlien et al., 1988; Thorburn et al., 1989;
Thresher et al., 2000) and thus may have a considerable effect
on cardiometabolic health if fructose is a significant component
of an LPHC diet.
AL HPLC diets were associated with decreased insulin sen-
sitivity, indicated by elevated circulating insulin, HOMA, and
pancreatic glucagon. This metabolic dysregulation may beCeattributed to the upregulation of gluconeogenesis, subsequently
increasing glycogen turnover and total hepatic glucose output
(Eisenstein et al., 1974; Linn et al., 2000). Whereas HPLC diets
do not sustain optimal late-life cardiometabolic health, it is
important to note that nutritional requirements change with
age, and higher P:C diets are required to support reproduction
rather than sustain maximal lifespan (Simpson et al., 2015; So-
lon-Biet et al., 2014, 2015).
Here, we have compared the metabolic effects of short-term
CR and AL LPHC diets in mice. The results of this study sug-
gest that it may be possible to titrate the balance of macronu-
trients to gain some of the metabolic benefits of CR, without the
challenge of a 40% reduction in caloric intake. A central priority
is to further investigate and compare the long-term effects of
traditional CR and AL LPHC diets on metabolic health and life-
span in mice and other model organisms, as well as to begin to
consider the effects of the type and quality of proteins and
carbohydrates.EXPERIMENTAL PROCEDURES
Animals and Dietary Interventions
Male C57BL6/Jmice (3 weeks old; n = 90; Jackson Laboratory) were housed in
groups of five at the National Institute of Aging. Animals were kept at 22C un-
der a 12:12-hr light-dark cycle (12-hr dark period starting at 18:00), and were
micro-chipped (Biomedic Data Systems) for individual identification and tem-
perature quantification. All animal protocols were approved by the Geron-
tology Research Center Animal Care and Use Committee (352-LEG-2012) of
the National Institute on Aging.ll Reports 11, 1529–1534, June 16, 2015 ª2015 The Authors 1531
Figure 3. Hepatic and Pancreatic Pathology
(A–F) Representative figures are shown of livers stained with H&E (A and B),
scanning electron microscopy of the liver sinusoidal endothelium (C and D),
and glucagon stains of the pancreatic islets (E and F).
(G) The effect of diets on pancreatic glucagon staining. Percentages indicate
the proportion of samples with high-intensity staining.
AL, ad libitum; CR, caloric restricted; HPLC, high ratio of protein to carbohy-
drate; MPMC, medium protein to carbohydrate ratio; LPHC, low protein to
carbohydrate ratio; p values provided in Table S2. See also Figure S1 and
Table S2.Three experimental diets were formulated that differed in protein to carbo-
hydrate ratios based on Solon-Biet et al. (2014). These diets were classified
as low protein, high carbohydrate (5% protein; LPHC); medium protein, me-
dium carbohydrate (33% protein; MPMC); and high protein, low carbohydrate
(60% protein, HPLC). Fat was fixed at 20% of total energy for all three diets.
Experimental diets were isocaloric (4 kcal/g) and contained the same ingredi-
ents (Table S1). All diets were manufactured in dry pelleted form by Dyets.
Mice were assigned to one of six different dietary regimens: ad libitum access
to diets where the protein to carbohydrate ratio was either high (AL HPLC), me-
dium (AL MPMC), or low (AL LPHC), and caloric restricted access to diets
where the protein to carbohydrate ratio was either high (CR HPLC), medium
(CR MPMC), or low (CR LPHC).
At 8 weeks of age, mice underwent a 4-day acclimatization period of a
50/50 food combination of standard chow and experimental diet, followed
by solely experimental diets for the remainder of the study. Mice were1532 Cell Reports 11, 1529–1534, June 16, 2015 ª2015 The Authorsrandomly assigned to either an AL- or a 40% CR-feeding regimen. Bi-
weekly food measurements of AL animals were used to calculate daily por-
tions for CR-fed mice, where food was reduced increments of 10% starting
at 20% until mice reached 40% CR. AL animals were allowed free access
to respective diets for 8 weeks and were fed in the hopper, while CR mice
were fed daily at approximately 8 a.m. ± 1 hr, with pellets dropped onto the
cage of the floor. Body weights and temperature were recorded bi-weekly
and food intakes for all groups were quantified at the same time.
After 8 weeks of feeding, mice were euthanized and blood and tissues
were collected for histological and biochemical analyses. On the day of
the sacrifice, CR mice were not fed while AL mice were allowed to eat
normally.
Body Composition
Fat, lean, and fluid mass of mice were measured using nuclear magnetic reso-
nance imaging (NMR) with the Minispec LF90 (Bruker Optics). Unanesthetized
mice were weighed and then scanned.
Glucose and Insulin
Oral glucose tolerance tests (OGTTs) were performed after 8 weeks of exper-
imental diets. Mice were fasted overnight (16 hr) prior to testing then gavaged
with a 30% glucose solution (1.5 g kg1 body weight) and blood glucose mea-
surements recorded at 0, 15, 30, 60, and 120 min via tail snip using a handheld
glucometer (Bayer). The incremental area under the curve was calculated us-
ing mean values per cage. Insulin was measured in fasting blood samples us-
ing an enzyme-linked immunosorbent assay (Crystal Chem). The homeostatic
model assessment (HOMA; http://www.dtu.ox.ac.uk/homa), which reflects in-
sulin resistance, was determined from the product of the fasting glucose and
insulin.
Metabolic Rate
In order to estimate whole-animal metabolic rate, substrate utilization, and
physical activity, eight animals per group were housed individually and
assessed by indirect calorimetry in an open-circuit oxymax chamber
(Comprehensive Lab Animal Monitory System, CLAMS; Columbus Instru-
ments). Oxygen consumption (VO2) and carbon dioxide production (VCO2)
were measured over 48 hr and maintained at 24C under at 12:12-hr light-
dark cycle. Mice were acclimatized to metabolic cage conditions for 8 hr prior
to the start of data recording. The respiratory exchange ratio (RER) was calcu-
lated as a ratio of VCO2 produced/ VO2 consumed. An RER of 0.7 indicates
that fat is the predominant fuel source, while an RER closer to 1.0 indicates
that carbohydrate is the primary fuel.
Liver and Pancreatic Pathology
Paraffin-embedded liver tissue was sectioned and stained with H&E.
Embedded pancreas tissue was sectioned and probed with monoclonal
anti-glucagon antibody (Sigma G2654), monoclonal anti-insulin antibody
(Sigma I2018), and anti-mouse IgG1 produced in rabbit (Sigma
SAB3701171). The extent of fatty liver and glucagon staining intensity was
assessed and scored (0, +, ++, +++) by four independent observers blinded
to the tissue category. Liver tissue was also needle-perfused with saline,
followed by 3% glutaraldehyde/2% paraformaldehyde in 0.1 M sodium
cacodylate buffer (pH 7.4), 2% (w/v) sucrose, and 2 mM CaCl2. Following
post-fixation with osmium tetroxide, graded dehydration in ethanol and
hexamethyldisilazane, 1-mm3 blocks of liver were sputter coated with plat-
inum and examined using a JEOL 6380 scanning electron microscope
(JEOL) at 20,000X magnification. Ten random images were taken per sample
and fenestration diameter analyzed using ImageJ software (Cogger et al.,
2015).
Statistical Analysis
Data are presented asmean ±SEM, and differences are considered significant
when p < 0.05. Comparisons between feeding regimens and diets on various
responses were analyzed using ANOVA and post hoc Fisher’s LSD tests when
indicated. Fisher’s LSD test was used to test for differences between AL LPHC
and CR diets. Two-group comparisons were performed using Student’s t tests
and Mann-Whitney rank sum tests (Sigmaplot v.11.2.0.5, Systat Software).
Figure 4. Indirect Calorimetry ± SEM
The effect of diets on (A) RER, (B) energy expen-
diture, and (C) body fat. AL, ad libitum; CR, caloric
restricted; HPLC, high ratio of protein to carbo-
hydrate; MPMC, medium protein to carbohydrate
ratio; LPHC, low protein to carbohydrate ratio. See
also Table S2.Intensity of glucagon and insulin staining was compared using a chi-square
test in Microsoft Excel.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two figures and three tables and can
be found with this article online at http://dx.doi.org/10.1016/j.celrep.2015.
05.007.
AUTHOR CONTRIBUTIONS
S.M.S.-B. designed and performed the experiments, analyzed the data, and
wrote the manuscript. S.J.M. performed the experiments. S.C.P.C. wrote
the manuscript and contributed to data analysis. V.C.C. and R.G. performed
the histology. A.C.M. assisted in preparation of histological samples. V.C.C.,
D.R., and R.d.C. assisted in the preparation of the manuscript. D.G.L.C. and
S.J.S. supervised the project, analyzed the data, and wrote the manuscript.
ACKNOWLEDGMENTS
This work was supported by the National Health and Medical Research Coun-
cil (NHMRC) of Australia (Project grant 571328, Program grant 571408), and
the Ageing and Alzheimers Institute (AAAI) of Concord Hospital. This study
was funded in part by the National Institute on Aging Intramural Research Pro-
gram of the National Institutes of Health. S.J.M. was supported by a National
Medical Health and Research Council of Australia CJ Martin Early Career
Fellowship (RGMS ID 2010-01671). R.d.C is supported by the Intramural
Research Program of the National Institute on Aging. D.R. is an Adjunct Profes-
sor in the New Zealand Institute for Advanced Study,Massey University, Auck-
land. We are grateful to Dawn Nines, Justine Lucas, and Dawn Phillips-Boyer
for their animal care and assistance. We also thank Dr. Alistair Senior for his
helpful comments and advice.CeReceived: February 4, 2015
Revised: April 16, 2015
Accepted: May 5, 2015
Published: May 28, 2015
REFERENCES
Ajala, O., English, P., and Pinkney, J. (2013). Systematic review andmeta-anal-
ysis of different dietary approaches to themanagement of type 2 diabetes. Am.
J. Clin. Nutr. 97, 505–516.
Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., Tran,
H., Ross, S.E., Mostoslavsky, R., Cohen, H.Y., et al. (2004). Stress-dependent
regulation of FOXO transcription factors by the SIRT1 deacetylase. Science
303, 2011–2015.
Cogger, V.C., O’Reilly, J.,Warren, A., and Le Couteur, D.G. (2015). A standard-
ized method for the analysis of liver sinusoidal endothelial cells and their fen-
estrations by scanning electron microscopy. J. Vis. Exp., e52698. http://dx.
doi.org/10.3791/52698.
Dietrich, P., and Hellerbrand, C. (2014). Non-alcoholic fatty liver disease,
obesity and the metabolic syndrome. Best Pract. Res. Clin. Gastroenterol.
28, 637–653.
Eisenstein, A.B., Strack, I., and Steiner, A. (1974). Glucagon stimulation of he-
patic gluconeogenesis in rats fed a high-protein, carbohydrate-free diet. Meta-
bolism 23, 15–23.
Everitt, A.V., Rattan, S.I., Le Couteur, D.G., and de Cabo, R. (2010). Calorie Re-
striction, Aging and Longevity (Springer).
Fontana, L., and Partridge, L. (2015). Promoting health and longevity through
diet: from model organisms to humans. Cell 161, 106–118.
Fontana, L., Partridge, L., and Longo, V.D. (2010). Extending healthy life
span—from yeast to humans. Science 328, 321–326.ll Reports 11, 1529–1534, June 16, 2015 ª2015 The Authors 1533
Fung, T.T., van Dam, R.M., Hankinson, S.E., Stampfer, M., Willett, W.C., and
Hu, F.B. (2010). Low-carbohydrate diets and all-cause and cause-specific
mortality: two cohort studies. Ann. Intern. Med. 153, 289–298.
Gosby, A.K., Conigrave, A.D., Lau, N.S., Iglesias, M.A., Hall, R.M., Jebb, S.A.,
Brand-Miller, J., Caterson, I.D., Raubenheimer, D., and Simpson, S.J. (2011).
Testing protein leverage in lean humans: a randomised controlled experi-
mental study. PLoS ONE 6, e25929.
Gosby, A.K., Conigrave, A.D., Raubenheimer, D., and Simpson, S.J. (2014).
Protein leverage and energy intake. Obes. Rev. 15, 183–191.
Huang, X., Hancock, D.P., Gosby, A.K., McMahon, A.C., Solon, S.M., Le Cou-
teur, D.G., Conigrave, A.D., Raubenheimer, D., and Simpson, S.J. (2013). Ef-
fects of dietary protein to carbohydrate balance on energy intake, fat storage,
and heat production in mice. Obesity (Silver Spring) 21, 85–92.
Lagiou, P., Sandin, S., Lof, M., Trichopoulos, D., Adami, H.O., and Weider-
pass, E. (2012). Low carbohydrate-high protein diet and incidence of cardio-
vascular diseases in Swedish women: prospective cohort study. BMJ 344,
e4026.
Le Couteur, D.G., McLachlan, A.J., Quinn, R.J., Simpson, S.J., and de Cabo,
R. (2012). Aging biology and novel targets for drug discovery. J. Gerontol. A
Biol. Sci. Med. Sci. 67, 168–174.
LeCouteur, D.G., Tay, S.S., Solon-Biet, S., Bertolino, P., McMahon, A.C., Cog-
ger, V.C., Colakoglu, F., Warren, A., Holmes, A.J., Pichaud, N., et al. (2014).
The influence of macronutrients on splanchnic and hepatic lymphocytes in ag-
ing mice. J. Gerontol. A Biol. Sci. Med. Sci., Published online October 21,
2014. http://dx.doi.org/10.1093/gerona/glu196.
Lee, K.P., Simpson, S.J., Clissold, F.J., Brooks, R., Ballard, J.W., Taylor, P.W.,
Soran, N., and Raubenheimer, D. (2008). Lifespan and reproduction in
Drosophila: New insights from nutritional geometry. Proc. Natl. Acad. Sci.
USA 105, 2498–2503.
Levine, M.E., Suarez, J.A., Brandhorst, S., Balasubramanian, P., Cheng, C.W.,
Madia, F., Fontana, L., Mirisola, M.G., Guevara-Aguirre, J., Wan, J., et al.
(2014). Low protein intake is associated with a major reduction in IGF-1, can-
cer, and overall mortality in the 65 and younger but not older population. Cell
Metab. 19, 407–417.
Linn, T., Santosa, B., Gro¨nemeyer, D., Aygen, S., Scholz, N., Busch, M., and
Bretzel, R.G. (2000). Effect of long-term dietary protein intake on glucose
metabolism in humans. Diabetologia 43, 1257–1265.
Maki, K.C., and Phillips, A.K. (2015). Dietary substitutions for refined carbohy-
drate that show promise for reducing risk of type 2 diabetes in men and
women. J. Nutr. 145, 159S–163S.
Masoro, E.J. (2005). Overview of caloric restriction and ageing. Mech. Ageing
Dev. 126, 913–922.
Mattison, J.A., Roth, G.S., Beasley, T.M., Tilmont, E.M., Handy, A.M., Herbert,
R.L., Longo, D.L., Allison, D.B., Young, J.E., Bryant, M., et al. (2012). Impact of
caloric restriction on health and survival in rhesusmonkeys from the NIA study.
Nature 489, 318–321.1534 Cell Reports 11, 1529–1534, June 16, 2015 ª2015 The AuthorsMcCay, C., Crowell, M., and Maynard, L. (1935). The effect of retarded growth
upon the length of life and upon ultimate size. J. Nutr. 10, 63–79.
Mercken, E.M., Carboneau, B.A., Krzysik-Walker, S.M., and de Cabo, R.
(2012). Of mice and men: the benefits of caloric restriction, exercise, and mi-
metics. Ageing Res. Rev. 11, 390–398.
Nseir, W., Hellou, E., and Assy, N. (2014). Role of diet and lifestyle changes in
nonalcoholic fatty liver disease. World J. Gastroenterol. 20, 9338–9344.
Piper, M.D., Partridge, L., Raubenheimer, D., and Simpson, S.J. (2011). Dietary
restriction and aging: a unifying perspective. Cell Metab. 14, 154–160.
Raubenheimer, D., Machovsky-Capuska, G.E., Gosby, A.K., and Simpson, S.
(2015). Nutritional ecology of obesity: from humans to companion animals. Br.
J. Nutr. 113, S26–S39.
Simpson, S.J., and Raubenheimer, D. (2005). Obesity: the protein leverage hy-
pothesis. Obes. Rev. 6, 133–142.
Simpson, S.J., Le Couteur, D.G., and Raubenheimer, D. (2015). Putting the
balance back in diet. Cell 161, 18–23.
Solon-Biet, S.M., McMahon, A.C., Ballard, J.W.O., Ruohonen, K., Wu, L.E.,
Cogger, V.C., Warren, A., Huang, X., Pichaud, N., Melvin, R.G., et al. (2014).
The ratio of macronutrients, not caloric intake, dictates cardiometabolic
health, aging, and longevity in ad libitum-fed mice. Cell Metab. 19, 418–430.
Solon-Biet, S.M.,Walters, K.A., Simanainen, U.K., McMahon, A.C., Ruohonen,
K., Ballard, J.W.O., Raubenheimer, D., Handelsman, D.J., Le Couteur, D.G.,
and Simpson, S.J. (2015). Macronutrient balance, reproductive function, and
lifespan in aging mice. Proc. Natl. Acad. Sci. USA 112, 3481–3486.
Sørensen, A., Mayntz, D., Raubenheimer, D., and Simpson, S.J. (2008). Pro-
tein-leverage in mice: the geometry of macronutrient balancing and conse-
quences for fat deposition. Obesity (Silver Spring) 16, 566–571.
Stock, M.J. (1999). Gluttony and thermogenesis revisited. Int. J. Obes. Relat.
Metab. Disord. 23, 1105–1117.
Storlien, L.H., Kraegen, E.W., Jenkins, A.B., and Chisholm, D.J. (1988). Effects
of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity
in rats. Am. J. Clin. Nutr. 47, 420–427.
Thorburn, A.W., Storlien, L.H., Jenkins, A.B., Khouri, S., and Kraegen, E.W.
(1989). Fructose-induced in vivo insulin resistance and elevated plasma tri-
glyceride levels in rats. Am. J. Clin. Nutr. 49, 1155–1163.
Thresher, J.S., Podolin, D.A., Wei, Y., Mazzeo, R.S., and Pagliassotti, M.J.
(2000). Comparison of the effects of sucrose and fructose on insulin action
and glucose tolerance. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279,
R1334–R1340.
Weindruch, R., Walford, R.L., Fligiel, S., and Guthrie, D. (1986). The retardation
of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime
energy intake. J. Nutr. 116, 641–654.
Wylie-Rosett, J., Segal-Isaacson, C.J., and Segal-Isaacson, A. (2004). Carbo-
hydrates and increases in obesity: does the type of carbohydrate make a dif-
ference? Obes. Res. 12 (Suppl 2), 124S–129S.
